Intelligent Bio Solutions eliminates Series B and Series D preferred stock designations

INTELLIGENT BIO SOLUTIONS INC.

Filed Certificates of Elimination for Series B and Series D Convertible Preferred Stock with Delaware SOS.
No shares of either series were outstanding; elimination reverts them to undesignated preferred shares.
Procedural charter amendment; no impact on common stock or shareholder rights.
Exact text of certificates filed as Exhibits 3.1 and 3.2 to the 8-K.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

INTELLIGENT BIO SOLUTIONS INC.: Elimination of Series B and Series D Convertible Preferred Stock designations, shares reverted to undesignated preferred stock (effective 2023-07-25).

Change: charter amendment
Effective: 2023-07-25

Exact text from the filing

On July 25, 2023, Intelligent Bio Solutions Inc. (the “Company”) filed a Certificate of Elimination of Series B Convertible Preferred Stock (the “Series B Certificate of Elimination”) with the Secretary of State of the State of Delaware (the “Delaware SOS”) effecting the elimination of its Series B Convertible Preferred Stock.

View on SEC.gov

Browse all governance changes →

INTELLIGENT BIO SOLUTIONS INC. filing history →

Source: SEC EDGAR

accession 0001493152-23-025589

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.